Virtual Nurse-Social worker team aims to ease symptoms for veterans with heart failure and COPD
NCT ID NCT07714252
First seen Jul 20, 2026 · Last updated Aug 25, 2026 · Updated 3 times
Summary
Many Veterans with heart failure or COPD struggle with breathlessness, fatigue, depression, and anxiety that routine care often misses. This study tests whether a virtual team—a nurse and a social worker—can improve quality of life by helping Veterans manage their most bothersome symptoms and providing brief counseling. The team works by phone or video and coordinates with the Veteran's primary care doctor. The study also looks at how well VA medical centers can adopt this program.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a virtual nurse and social worker team providing symptom management and counseling by phone or video
- What this could lead to
- If successful, this approach could offer a scalable way to improve quality of life and emotional well-being for Veterans with serious lung or heart conditions.
- What could go wrong
- This is a behavioral intervention study, so results depend on participant engagement and may not generalize beyond the VA system. The trial is also relatively small (420 participants).
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 420 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2026
- Expected to finish
-
Sep 2030
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * At least one primary care encounter in the past year, identified by primary care stop codes (301, 322, 323, 342, 348, 350, 704) * Diagnosed with heart failure, chronic obstructive pulmonary disease (COPD), or interstitial lung disease, defined as 2 or more outpatient or community care provider visit encounters with a qualifying International Classification of Diseases (ICD) code at least 30 days apart, or 1 inpatient hospitalization with a qualifying ICD code as the primary discharge diagnosis, within the past year * Care Assessment Need (CAN) 3.0 score ≥ 90 at some point in the prior 6 months * Poor self-reported quality of life, defined as a Functional Assessment of Chronic Illness Therapy-General (FACT-G) score ≤ 70 at screening * Consistent access to a telephone Exclusion Criteria: * Dementia diagnosis (any inpatient, outpatient, or community care encounter with qualifying International Classification of Diseases (ICD) code in the prior 3 years) * Cancer diagnosis (2 or more outpatient or community care provider visit encounters, or 1inpatient primary discharge diagnosis, with a qualifying ICD code in the prior 1 year) * Current substance misuse (at least 1 inpatient or outpatient encounter with a qualifying substance/alcohol ICD code or stop code in the prior 6 months) * Currently receiving palliative care (at least 1 inpatient or outpatient encounter with palliative care stop codes 351 or 353 in the prior 1 year)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
7 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Cheyenne VA Medical, Cheyenne, WY
Cheyenne, Wyoming, 82001, United States
-
Lebanon VA Medical Center, Lebanon, PA
Lebanon, Pennsylvania, 17042-7529, United States
-
Overton Brooks VA Medical Center, Shreveport, LA
Shreveport, Louisiana, 71101-4243, United States
-
Phoenix VA Health Care System, Phoenix, AZ
Phoenix, Arizona, 85012, United States
-
Providence VA Medical Center, Providence, RI
Providence, Rhode Island, 02908-4734, United States
-
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado, 80045-7211, United States
-
VA Long Beach Healthcare System, Long Beach, CA
Long Beach, California, 90822, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The impact of video-based cardiac rehabilitation education in patients with cardiovascular implantable electronic Devices(CIEDs)- a randomized controlled trial
- Effect of the use of dapagliflozin in diuresis, natriuresis and in ultrafiltration and peritoneal elimination of sodium, in patients with refractory heart failure
- Can rehabilitation boost confidence in fibrotic lung disease?
- Can a 10-Week coaching program ease the toll on heart failure caregivers?
- Inhaled therapy aims to slow the march of progressive pulmonary fibrosis
- Can a 10-Second chest scan reveal hidden heart clues?